Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
Slideshow
-
Farxiga (dapagliflozin; AstraZeneca)
Indication: As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
-
Tanzeum (albiglutide; GlaxoSmithKline)
Indication: As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
-
Jardiance (empagliflozin; Boehringer Ingelheim and Lilly)
Indication: As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
-
Invokamet (canagliflozin, metformin HCl; Janssen)
Indication: As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus who are not adequately controlled on a regimen containing metformin or canagliflozin or who are already being treated with both canagliflozin and metformin.
-
Trulicity (dulaglutide; Lilly)
Indication: As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
-
Xigduo XR (dapagliflozin, metformin HCl ext-rel; AstraZeneca)
Indication: As an adjunct treatment to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both dapagliflozin and metformin is appropriate.
